BCL2A1 mRNA expression was detected both in IL-17A-treated Mo-DCs from healthy controls and in IL-17A-producing Mo-DCs from LCH patients, but not in untreated Mo-DCs from healthy controls (Supplementary Figure 1). Here, BCL2A1 is linked to Langerhans cell histiocytosis.